![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 46, 43221-43230, November 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
§,
¶
,
¶, and
¶**
From the Human Molecular Biology Group, James Graham Brown Cancer
Center, Departments of The discovery of G-rich oligonucleotides (GROs)
that have non-antisense antiproliferative activity against a number of
cancer cell lines has been recently described. This biological activity of GROs was found to be associated with their ability to form stable
G-quartet-containing structures and their binding to a specific
cellular protein, most likely nucleolin (Bates, P. J., Kahlon,
J. B., Thomas, S. D., Trent, J. O., and Miller, D. M. (1999) J. Biol. Chem. 274, 26369-26377). In this
report, we further investigate the novel mechanism of GRO activity by
examining their effects on cell cycle progression and on nucleic acid
and protein biosynthesis. Cell cycle analysis of several tumor cell
lines showed that cells accumulate in S phase in response to treatment with an active GRO. Analysis of 5-bromodeoxyuridine incorporation by
these cells indicated the absence of de novo DNA synthesis, suggesting an arrest of the cell cycle predominantly in S phase. At the
same time point, RNA and protein synthesis were found to be ongoing,
indicating that arrest of DNA replication is a primary event in
GRO-mediated inhibition of proliferation. This specific blockade of DNA
replication eventually resulted in altered cell morphology and
induction of apoptosis. To characterize further GRO-mediated inhibition
of DNA replication, we used an in vitro assay based on
replication of SV40 DNA. GROs were found to be capable of inhibiting
DNA replication in the in vitro assay, and this activity
was correlated to their antiproliferative effects. Furthermore, the
effect of GROs on DNA replication in this assay was related to their
inhibition of SV40 large T antigen helicase activity. The data
presented suggest that the antiproliferative activity of GROs is a
direct result of their inhibition of DNA replication, which may result
from modulation of a replicative helicase activity.
Medicine,
§ Pharmacology/Toxicology, ¶ Biochemistry/Molecular
Biology, and
Chemistry, University of Louisville,
Louisville, Kentucky 40202
This article has been cited by other articles:
![]() |
S. Soundararajan, W. Chen, E. K. Spicer, N. Courtenay-Luck, and D. J. Fernandes The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells Cancer Res., April 1, 2008; 68(7): 2358 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Teng, A. C. Girvan, L. K. Casson, W. M. Pierce Jr., M. Qian, S. D. Thomas, and P. J. Bates AS1411 Alters the Localization of a Complex Containing Protein Arginine Methyltransferase 5 and Nucleolin Cancer Res., November 1, 2007; 67(21): 10491 - 10500. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qi, C.-P. Lin, X. Fu, L. M. Wood, A. A. Liu, Y.-C. Tsai, Y. Chen, C. M. Barbieri, D. S. Pilch, and L. F. Liu G-Quadruplexes Induce Apoptosis in Tumor Cells Cancer Res., December 15, 2006; 66(24): 11808 - 11816. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Ireson and L. R. Kelland Discovery and development of anticancer aptamers Mol. Cancer Ther., December 1, 2006; 5(12): 2957 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Benimetskaya, K. Ayyanar, N. Kornblum, D. Castanotto, J. Rossi, S. Wu, J. Lai, B. D. Brown, N. Popova, P. Miller, et al. Bcl-2 Protein in 518A2 Melanoma Cells In vivo and In vitro. Clin. Cancer Res., August 15, 2006; 12(16): 4940 - 4948. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Girvan, Y. Teng, L. K. Casson, S. D. Thomas, S. Juliger, M. W. Ball, J. B. Klein, W. M. Pierce Jr., S. S. Barve, and P. J. Bates AGRO100 inhibits activation of nuclear factor-{kappa}B (NF-{kappa}B) by forming a complex with NF-{kappa}B essential modulator (NEMO) and nucleolin. Mol. Cancer Ther., July 1, 2006; 5(7): 1790 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abdelrahim, C. H. Baker, J. L. Abbruzzese, and S. Safe Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. J Natl Cancer Inst, June 21, 2006; 98(12): 855 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiang, X.-S. Xu, and J. E. Russell A Nucleolin-Binding 3' Untranslated Region Element Stabilizes {beta}-Globin mRNA In Vivo. Mol. Cell. Biol., March 1, 2006; 26(6): 2419 - 2429. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jing, Q. Zhu, P. Yuan, Y. Li, L. Mao, and D. J. Tweardy Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol. Cancer Ther., February 1, 2006; 5(2): 279 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis Cancer Res., September 15, 2004; 64(18): 6603 - 6609. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Yoo, E. Bochkareva, A. Bochkarev, T.-C. Mou, and D. M. Gray 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro Nucleic Acids Res., April 2, 2004; 32(6): 2008 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Leliveld, R. T. Dame, M. A. Mommaas, H. K. Koerten, C. Wyman, A. A. A. M. Danen-van Oorschot, J. L. Rohn, M. H. M. Noteborn, and J. P. Abrahams Apoptin protein multimers form distinct higher-order nucleoprotein complexes with DNA Nucleic Acids Res., August 15, 2003; 31(16): 4805 - 4813. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dapic, V. Abdomerovic, R. Marrington, J. Peberdy, A. Rodger, J. O. Trent, and P. J. Bates Biophysical and biological properties of quadruplex oligodeoxyribonucleotides Nucleic Acids Res., April 15, 2003; 31(8): 2097 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mi, S. D. Thomas, X. Xu, L. K. Casson, D. M. Miller, and P. J. Bates Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin J. Biol. Chem., February 28, 2003; 278(10): 8572 - 8579. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |